<DOC>
	<DOCNO>NCT02203552</DOCNO>
	<brief_summary>This randomize clinical trial study well minocycline hydrochloride work reduce chemotherapy induce depression anxiety patient stage I-III breast cancer . Minocycline hydrochloride may prevent change memory think improve quality life breast cancer patient receive chemotherapy .</brief_summary>
	<brief_title>Minocycline Hydrochloride Reducing Chemotherapy Induced Depression Anxiety Patients With Stage I-III Breast Cancer</brief_title>
	<detailed_description>PRIMARY OBJECTIVES : I . To evaluate anxiety depression woman stag I-III breast cancer first 8 week doxorubicin-based adjuvant therapy randomize receive either minocycline ( minocycline hydrochloride ) placebo . II . To evaluate marker neuro-inflammation assess blood base inflammatory cytokine C11-choline positron emission tomography ( PET ) woman stag I-III breast cancer first 8 week doxorubicin-based adjuvant therapy randomize receive either minocycline placebo . OUTLINE : Patients randomize 1 2 arm . ARM I : Beginning 1 week prior chemotherapy , patient receive minocycline hydrochloride orally ( PO ) twice daily ( BID ) 9 week . ARM II : Beginning 1 week prior chemotherapy , patient receive placebo PO BID 9 week . After completion study treatment , patient follow 6 month .</detailed_description>
	<mesh_term>Breast Neoplasms</mesh_term>
	<mesh_term>Depression</mesh_term>
	<mesh_term>Depressive Disorder</mesh_term>
	<mesh_term>Anxiety Disorders</mesh_term>
	<mesh_term>Minocycline</mesh_term>
	<criteria>Women diagnose breast cancer stag IIII initiate first line adjuvant neoadjuvant doxorubicin hydrochloride ( DOX ) chemotherapy Postmenopausal define amenorrhea &gt; 12 month follicle stimulate hormone ( FSH ) estradiol institutional postmenopausal range Ability understand English read write 8th grade level give write informed consent document Rheumatoid arthritis type autoimmune inflammatory joint disease , exception osteoarthritis fibromyalgia Concurrent malignancy metastatic malignancy kind Reported diagnosis major depression anxiety disorder prior breast cancer ( BC ) diagnosis Currently prescribe psychotropic medication include antidepressant Known bleed disorder History diabetes mellitus , heart disease stroke Current use warfarin anticoagulant Uncontrolled intercurrent illness include , limited , ongoing active infection , symptomatic congestive heart failure , unstable angina pectoris , cardiac arrhythmia , hypertension , psychiatric illness/social situation would limit compliance study requirement Pregnant nursing woman Concurrent use daily full dose aspirin ( &gt; = 325 mg/day ) , nonsteroidal antiinflammatory drug ( NSAIDs ) NSAIDcontaining product steroid ; one month washout period require prior randomization Unable give inform consent Tetracycline allergy Any contraindication magnetic resonance imaging ( MRI ) /PET examination include limited ferromagnetic metal body , pacemaker , severe claustrophobia ; ( however , portion optional patient otherwise eligible , enroll study without participate image study )</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>Breast Cancer</keyword>
</DOC>